Adriana Ionelia Apostol

6PUBLICATIONS
44CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Adriana I Apostol, Jacek Gronwald, Cezary Cybulski

|Dec 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe

|Nov 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer.

Claudia Marchetti, Gwenael Ferron, Olivier Colomban

|Nov 04, 2025
Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacy.

Adriana Ionelia Apostol, Matteo Bruno, Carolina Maria Sassu

|Jun 12, 2024
Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?

Serena Maria Boccia, Carolina Maria Sassu, Raffaella Ergasti

|Jun 10, 2024
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients.

Matteo Bruno, Adriana Ionelia Apostol, Serena Maria Boccia

Pageof 1